Journal of Medical Microbiology · 2008 · 34 citations · 15 references
Life SciencesInfectious DiseasesMicrobiologyHost-pathogen InteractionsMedical MicrobiologyMicrobial PathogenesisBacterial InfectionsBacterial PathogenesisCell-surface GlycansGlycan-protein InteractionsPathogen AdhesionPathogenesis Of Infectious DiseaseEscherichia ColiGlycan Recognition In Microbial AdhesionGlycan-mediated BindingHeparan Sulfate ProteoglycansHost-pathogen Glycan RecognitionPathogen AdhesinsPathogen Adhesion To GlycansPathogen Attachment Glycans
We recently showed that OmcB protein from Chlamydia trachomatis serovar LGV1 functions as an adhesin. In this study, we produced Escherichia coli expressing OmcB from serovar E and compared this OmcB to OmcB from serovar LGV1. Infectivity inhibition assays carried out with serovars LGV1 and E of C. trachomatis in the presence of recombinant OmcB showed considerable (approximately 60%) inhibition of infectivity. In the presence of heparan sulphate, there was significant inhibition (68%) of adherence of E. coli expressing OmcB from serovar LGV1 only. In a further experiment, recombinant OmcB from serovar LGV1 showed minimal binding to glycosaminoglycan (GAG)-deficient cells, whilst to the same cells, recombinant OmcB from serovar E showed binding equal to that to the wild-type cells. Our experiments strongly suggest that OmcB from serovar E, in contrast to that from serovar LGV1, is not binding to host cells through a GAG-dependent mechanism.
15
Interaction of chlamydiae and host cells in vitro.
J W Moulder · Microbiological Reviews · 1991 · 328 citations · Full text
Mechanism of C. trachomatis attachment to eukaryotic host cells
Richard S. Stephens · Cell · 1992 · 246 citations